Table I.
Clock genes | Cancer types | Other diseases | References |
---|---|---|---|
Bmal1 | Breast, colorectal, head and neck, ovarian, pancreatic, and prostate cancers, B-cell lymphoma, pleural mesothelioma, ALL, AML, and CML | Aging, hypertension, immune deficiency, mood disorders, neurodegeneration, and T2D | (45, 96–108) |
CK1δ/ε | Breast, colorectal, ovarian, pancreatic, and prostate cancers | Aging, chronic inflammation, hypertension, insulin resistance, neurodegeneration, and sleep disorders | (102, 120–135) |
Clock | Breast, colorectal, lung, ovarian, pancreatic, prostate and skin cancers, B-cell lymphoma, and CLL | Bipolar disorder, hypertension, obesity, neurodegeneration, NAFLD, and T2D | (50, 102–104, 106, 139–144) |
Cry1/2 | Breast, colorectal, endometrial, head and neck, ovarian, pancreatic, prostate and skin cancers, glioma, pleural mesothelioma, CLL, CML, HCC, and NHL | Acute inflammation, hyperglycemia, mood disorders, obesity, Parkinson’s, and T2D | (102–105, 125, 126, 134, 139–140, 153–171) |
Dec1/2 | Breast, endometrial, gastric, head and neck, lung, pancreatic, and renal cancers, and HCC | Autoimmune disease, chronic inflammation, and sleep disorders | (182–194) |
Npas2 | Breast and prostate cancers, pleural mesothelioma, glioma, and NHL | Aging, chronic fatigue, chronic inflammation, hypertension, mood disorders, and neurodegeneration | (100, 102, 134, 161, 169, 197–204) |
Per1/2/3 | Breast, colorectal, endometrial, head and neck, lung, ovarian, pancreatic, prostate, skin and thyroid cancers, B-cell lymphoma, glioma, pleural mesothelioma, AML, CLL, CML, and HCC | Aging, cardiovascular disease, chronic inflammation, insulin resistance, neurodegeneration, obesity, eating, mood and sleep disorders, and T2D | (98, 99, 104, 105, 126, 134, 139, 140, 157, 158, 160, 161, 164, 169, 170, 213, 223, 229, 240) |
Rorα/γ | Breast, colorectal, pituitary, prostate, and thyroid cancers | Immune deficiency, insulin resistance, and obesity | (122, 255–264) |
Rev-erbα/β | Breast and thyroid cancers and pleural mesothelioma | Autoimmune disease, chronic inflammation, and obesity | (162, 256, 273–280) |
βTrCP1/2 | Breast, colorectal, gastric, pancreatic, and prostate cancers, and HCC | N/A | (284–289) |
ALL = acute lymphocytic leukemia; AML = acute myeloid leukemia; CLL = chronic lymphocytic leukemia; CML = chronic myeloid leukemia; HCC = hepatocellular carcinoma; NAFLD = non-alcoholic fatty liver disease; NHL = non-Hodgkin’s lymphoma; T2D = type 2 diabetes.